Inventor · disambiguated record
H. Trent Spencer
Also filed as: SPENCER H TRENT
11 granted patents·8 pending applications·40 citations·filing 1996–2024
87Inventor score
Files withUNIV EMORY11UNIV WAKE FOREST HEALTH SCIENCES4UAB RES FOUND2SPENCER H TRENT1ST JUDE CHILDRENS RES HOSPITAL1
Top patents by PatentIndex Score
19 records- 0193US10323077B2Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancerUNIV EMORY·Filed 2015·Granted Jun 18, 2019·12 cites·11 claims
- 0289US10654910B2Factor VIII proteins having ancestral sequences, expression vectors, and uses related theretoUNIV EMORY·Filed 2016·Granted May 19, 2020·7 cites·18 claims
- 0389US10058624B2Recombinant promoters and vectors for protein expression in liver and use thereofUNIV EMORY·Filed 2016·Granted Aug 28, 2018·11 cites·28 claims
- 0486US10724050B1CAS9 nucleic acid molecules and their useUNIV EMORY·Filed 2017·Granted Jul 28, 2020·3 cites·17 claims
- 0582US11046750B2Factor VIII proteins having ancestral sequences, expression vectors, and uses related theretoUNIV EMORY·Filed 2020·Granted Jun 29, 2021·1 cites·12 claims
- 0681US10898588B2Recombinant promoters and vectors for protein expression in liver and use thereofUNIV EMORY·Filed 2018·Granted Jan 26, 2021·1 cites·18 claims
- 0775US2025073228A1Genetically engineered drug resistant t cells and methods of using the sameUAB RES FOUND·Filed 2024·Application pending·0 cites
- 0873US11897938B2Factor VIII proteins having ancestral sequences, expression vectors, and uses related theretoUNIV EMORY·Filed 2021·Granted Feb 13, 2024·0 cites·9 claims
- 0967US11136369B2Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancerUNIV EMORY·Filed 2019·Granted Oct 5, 2021·0 cites·15 claims
- 1066US11634726B2Cas9 nucleic acid molecules and their useUNIV EMORY·Filed 2020·Granted Apr 25, 2023·0 cites·14 claims
- 1166US2024139253A1Post-Natal Transplantation Of Factor VIII-Expressing Cells For Treatment of HemophiliaUNIV WAKE FOREST HEALTH SCIENCES·Filed 2023·Application pending·0 cites
- 1266US2024066067A1In utero transplantation of factor viii-expressing cells for treatment of hemophiliaUNIV WAKE FOREST HEALTH SCIENCES·Filed 2023·Application pending·0 cites
- 1366US2021128751A1Recombinant promoters and vectors for protein expression in liver and use thereofUNIV EMORY·Filed 2021·Application pending·0 cites
- 1457US12005078B2Genetically engineered drug resistant T cells and methods of using the sameUAB RES FOUND·Filed 2016·Granted Jun 11, 2024·0 cites·30 claims
- 1553US2020368286A1In utero transplantation of factor viii-expressing cells for treatment of hemophiliaUNIV WAKE FOREST HEALTH SCIENCES·Filed 2018·Application pending·0 cites
- 1653US2020360441A1Post-natal transplantation of factor viii-expressing cells for treatment of hemophiliaUNIV WAKE FOREST HEALTH SCIENCES·Filed 2018·Application pending·0 cites
- 1750US2012258532A1Drug resistant immunotherapy for treatment of a cancerSPENCER H TRENT·Filed 2010·Application pending·0 cites
- 1841US2020179450A1T-cell antigen targeted chimeric antigen receptor (car) and uses in cell therapiesUNIV EMORY·Filed 2018·Application pending·0 cites
- 1930US6500421B1In vivo selection of primitive hematopoietic cellsST JUDE CHILDRENS RES HOSPITAL·Filed 1996·Granted Dec 31, 2002·5 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when H. Trent Spencer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →